Skip to content
GLP-1 Savers
Menu
Ranked #171 · Watch List

Kin Meds review

Kin Meds is a telehealth platform displaying a LegitScript certification badge on its own site offering both compounded GLP-1s (semaglutide from $199/mo, tirzepatide from $249/mo) and brand-name FDA-approved options including Wegovy injection.

By Grant Ashford, Founder & Pricing Editor

Est. first month

From $149/mo

From $149/mo (brand Wegovy)

FDA warning letter. The FDA issued Kin Meds a warning letter in February 2026. Check it on the FDA database.

Get this deal Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Value Score.
Pricing to watch. The published figure is a single-tier rate, not a price that is guaranteed at every dose.

How much does Kin Meds cost?

The price Kin Meds publishes is From $149/mo (brand Wegovy). We flag this one to watch: confirm the ongoing rate with Kin Meds before you count on it, because a low first month can step up afterward.

Semaglutide
From $149/mo (brand Wegovy)
Tirzepatide
From $149/mo (brand Zepbound)
Coverage
Coverage not published
Brand-name
Yes

The Value Score card

Kin Meds scored on our six published factors. See the methodology.

Lowest Real Price82/100
No Teaser-Rate Bait72/100
Nationwide Availability45/100
Both Molecules92/100
Easy Cancellation58/100
Reputation73/100

Why it's a deal

  • Publicly lists $199/mo compounded semaglutide and $249/mo compounded tirzepatide
  • Brand-name options too — Wegovy injection and pill, Zepbound, Foundayo from $149/mo entry pricing
  • LegitScript verified
  • Clearly identifies itself as the intake platform and a licensed third-party pharmacy as the dispenser
  • Broad longevity menu (Sermorelin, NAD+, Glutathione) plus TRT, hair, skin, and sexual health

Read the fine print

  • Legal entity name and state of incorporation not publicly disclosed
  • The third-party pharmacy partner isn't named, and Kin Meds isn't itself a licensed pharmacy
  • Per-state availability not listed
  • $149/mo brand pricing is the insured entry tier — cash-pay patients should expect higher real costs
  • Lab work and dose-titration support not clearly described

The bottom line

Best for: Shoppers who want compounded and brand-name GLP-1 plus a longevity stack on one platform. Kin Meds is a telehealth platform displaying a LegitScript certification badge on its own site offering both compounded GLP-1s (semaglutide from $199/mo, tirzepatide from $249/mo) and brand-name FDA-approved options including Wegovy injection.

Ranked #171 of 427 programs we track — see our #1 deal, CoreAge Rx, for comparison.

Compare with other deals

The programs scoring closest to Kin Meds, out of 426 others we track.

Shopping Kin Meds against a specific rival? We put it head to head with our top-scoring pick on CoreAge Rx vs Kin Meds, and every program that undercuts or outscores it — starting with Arc-1, the closest match on score — is ranked on the Kin Meds alternatives ranking.

More programs we track (24)

396 more are reviewed too — see every GLP-1 program we track, ranked.

Pricing and coverage on this page were read from Kin Meds's own website on ; the Value Score is our editorial judgment per the methodology. “% vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on Kin Meds's site. Not medical advice; see our disclosure.

See every program ranked by price →

← Back to all deals